Influenza A Virus Neuraminidase Antikörper (AA 50-100)
Dieses Anti-Influenza A Virus Neuraminidase-Antikörper ist ein Kaninchen Polyklonal-Antikörper zur Detektion von Influenza A Virus Neuraminidase in ELISA. Geeignet für Influenza A Virus H7N9.
Produktnummer ABIN5689892
Kurzübersicht für Influenza A Virus Neuraminidase Antikörper (AA 50-100) (ABIN5689892)
Avian Influenza A H7N9 Neuraminidase antibody is affinity chromatography purified via peptide column.
Immunogen
Avian Influenza A H7N9 Neuraminidase antibody was raised against a synthetic peptide corresponding to 11 amino acids near the amino terminus of the H7N9 [Influenza A virus (A/Shanghai/02/2013(H7N9))] Neuraminidase protein.
The immunogen is located within amino acids 50 - 100 of Avian Influenza A H7N9 Neuraminidase.
NA
Reaktivität: Influenza A Virus
ELISA
Wirt: Kaninchen
Polyclonal
unconjugated
Applikationshinweise
Avian Influenza A H7N9 Neuraminidase antibody can be used for detection of Avian Influenza A H7N9 Neuraminidase by ELISA at 1 μ,g/mL.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
1 mg/mL
Buffer
Avian Influenza A H7N9 Neuraminidase Antibody is supplied in PBS containing 0.02 % sodium azide.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
4 °C,-20 °C
Informationen zur Lagerung
Avian Influenza A H7N9 Neuraminidase antibody can be stored at 4°C for three months and -20°C, stable for up to one year.
Target
Influenza A Virus Neuraminidase (NA)
Andere Bezeichnung
Influenza A Virus Neuraminidase
Substanzklasse
Influenza Protein
Hintergrund
Influenza A virus is a major public health threat, killing more than 30,000 people per year in the USA (1). Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals, however it is in birds that all subtypes can be found (2). These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. H7N9 bird flu is the newest atypical influenza virus infection that has just been reported since early 2013. The emergence of this new strain occurred in China and has become the present focus for possible worldwide pandemic (3).